Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank14
3Y CAGR-10.3%
5Y CAGR-15.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-10.3%/yr
vs +11.2%/yr prior
5Y CAGR
-15.7%/yr
Recent acceleration
Acceleration
-21.6pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
5 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.07 | -6.9% |
| 2024 | 0.07 | -12.3% |
| 2023 | 0.08 | -11.6% |
| 2022 | 0.09 | -12.9% |
| 2021 | 0.11 | -32.4% |
| 2020 | 0.16 | +225.7% |
| 2019 | 0.05 | -20.1% |
| 2018 | 0.06 | -24.8% |
| 2017 | 0.08 | +16.3% |
| 2016 | 0.07 | - |